ArticleFrontiers in endocrinology2025
Simultaneous occurrence of bilateral retroperitoneal neuroblastoma and bifocal malignant mixed germ cell tumor in a pediatric patient with 16p11.2 microdeletion syndrome: a case report.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Central nervous system germ cell tumors are rare intracranial neoplasms that predominantly occur in pediatric populations and exhibit characteristics similar to those of gonadal and extragonadal germ cell tumors. Neuroblastoma (NB) represents the most common type of extracranial solid tumor in children, typically arising in tissues with sympathetic innervation. We present a case involving a 14-year-old male patient diagnosed with bilateral intracranial mixed germ cell tumors and concurrent bilateral retroperitoneal ganglioneuroblastoma. To the best of our knowledge, this is the first documented instance of the co-occurrence of these two distinct neoplastic entities. Additionally, Whole-exome sequencing (WES) of the blood sample identified a chromosomal deletion consistent with the 16p11.2 microdeletion syndrome. Furthermore, a heterozygous missense variant in the ALK gene (p. Arg1275Gln) was identified.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.